Skip to main content
Fig. 2 | BMC Veterinary Research

Fig. 2

From: Preserved bevacizumab (Avastin®) eye drops for application in multidose containers an in-vitro characterisation

Fig. 2

Immunoblotting of B-T0, BBAC-T0, B-T4, BBAC-T4 and A. a Representative example of bevacizumab detected after immunoblotting on a PVDF membrane. 10 ng (1), 25 ng (2) or 50 ng (3) were loaded per lane. Two distinct bands of 25 and 55 kDa were detected, corresponding to the light and heavy chains of the IgG molecule. (b/c) Densitometry analysis of the heavy (b) and light (c) chain (n = 2)

Back to article page